Apimeds Pharmaceuticals US, Inc.
APUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001894525
No open-market purchases or sales by Apimeds Pharmaceuticals US, Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $383.7K in total; no superinvestor holds it.
Holders of 5% or more of APUS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Apimeds Pharmaceuticals US, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Inscobee Inc. | 13D/A | 34.30%4.32M shares | 0.00 ppfrom 34.30% | May 19, 20255 filings | May 7, 2026 | SEC |
| Ayrton Capital LLC | 13G | 9.99%1.40M shares | New | Feb 11, 20261 filing | Feb 11, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Apimeds Pharmaceuticals US, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 7, 20269:11 AM ET | Inscobee Inc.and 1 other | 13D/A | 34.30%4.32M shares | 0.00 ppfrom 34.30% | May 7, 2026 | SEC |
| Mar 30, 20268:20 AM ET | Inscobee Inc.and 1 other | 13D/A | 34.30%4.32M shares | 0.00 ppfrom 34.30% | Mar 25, 2026 | SEC |
| Mar 20, 20266:21 PM ET | Inscobee Inc.and 1 other | 13D/A | 34.30%4.32M shares | 0.00 ppfrom 34.30% | Mar 20, 2026 | SEC |
| Feb 11, 20269:51 AM ET | Ayrton Capital LLCand 2 others | 13G | 9.99%1.40M shares | New | Dec 31, 2025 | SEC |
| Jan 26, 20266:03 AM ET | Inscobee Inc.and 1 other | 13D/A | 34.30%4.32M shares | −3.60 ppfrom 37.90% | Dec 1, 2025 | SEC |
| May 19, 20259:29 PM ET | Inscobee Inc.and 1 other | 13D | 37.90%4.39M shares | New | May 12, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Apimeds Pharmaceuticals US, Inc. shares.
No Form 144 notices for Apimeds Pharmaceuticals US, Inc. are on file.